Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Bromazepam manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Bangladesh

Clear all

4 products found

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084
Company provides a detailed list of medications, including both generic and sometimes brand names, each categorized by their therapeutic class, such as antihypertensives, antibiotics, analgesics, and vitamins. This classification helps medical professionals—like doctors, pharmacists, and nurses—quickly understand a drug’s purpose and its potential interactions with other medications, while also providing patients with insights into how their prescribed medications function. Researchers can leverage this data to examine medication use trends or to identify gaps in treatment options for certain conditions. This data can be further utilized by creating a searchable database, visualizing relationships between medications through charts or graphs, and comparing drugs within the same therapeutic class to analyze their uses, side effects, and dosage forms.

Manufacturer usually replies in 4 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
Philippines
Manufacturer #21042
This pharmaceutical company is dedicated to providing safe, effective, and affordable medications across various therapeutic areas. Their state-of-the-art manufacturing facility adheres to internationally recognized GMP standards, ensuring high quality and efficacy in their products. They offer a diverse range of solid and liquid dosage forms, including some novel medications "first time in Bangladesh." The company emphasizes continuous improvement and collaborates with stakeholders throughout the business process to maintain quality across all aspects, from production to customer service. They are expanding their presence in both the EU and North America, bringing affordable healthcare solutions to a global audience.

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Bromazepam:

Bromazepam, also known by its popular brand name of Lectopam, is an anti-anxiety medication with similar therapeutic effects and side effects to diazepam (Valium). It is predominantly used in the treatment of anxiety or panic states, as such, it has become a popularly prescribed premedication before surgery. It was originally produced by the pharmaceutical products company Roche, which patented it in 1961 and got it subsequently approved for commercialization on the medical marketplace in 1974. Currently, it has entered into the generic drugs space, commonly being produced and listed for sale by Bromazepam manufacturers and Bromazepam suppliers. However, due to its psychotropic properties and frequent abuse, it is classified as a schedule IV drug in the U.S. and Canada under the Convention on Psychotropic Substances, hindering its commercialization by manufacturers. Regardless, as a generic drug, it is often found available to order on the pharmaceutical products list of distributors across the global marketplace, where it can be found wholesale at a variety of cost and price points.

Method of action of Bromazepam:

Bromazepam belongs to a group of pharmaceutical products termed benzodiazepines. Specifically, it is a lipophilic, long and intermediate-acting benzodiazepine with sedative, hypnotic, anxiolytic, and skeletal muscle relaxant properties. It functions by binding to the GABA-A receptor, producing a conformational change and causing downstream effects, which in turn culminate in the observed clinical properties. Notably, it is specific in its activation, with other neurotransmitters not being influenced.

Form and dosage of Bromazepam:

The final form and packaging of Bromazepam are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, Bromazepam can typically be found wholesale in forms including tablets, oral drops, and capsules. For the treatment of excessive anxiety in adults, the typical dose ranges from 6 mg to 18 mg daily. This can be adjusted by the prescribing medical official, up to a recommended maximum dose of a total of 30 mg daily. The length of treatment should not exceed one week unless specifically prescribed as unwanted side effects may occur. Such as dependence and withdrawal symptoms when taken for extended periods. For a complete list of possible adverse effects please refer to the manufacturers’ literature or contact the prescribing healthcare provider.

Bromazepam on Pipelinepharma:

Currently, at the time of writing, we have found 15 verified bromazepam manufacturers and bromazepam suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located globally in countries including Mexico, the European Union, Brazil, and Jordan. Every company and their pharmaceutical product list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability while serving to reduce souring mileage, allowing for a fluent business experience for all involved parties.

Price of Bromazepam and how to buy:

A cursory search online reveals an approximate cost for wholesale Bromazepam to be 514- 722 USD/kg from India and 1,693 USD/kg from Italy. It should be noted that these indicated values do not represent finished dosage formulations and the price of Bromazepam, as with any drug, is highly dependent on the individual situation. As such, these indicated values only serve as a generalisation of the current market condition.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation